Biogen resurrects Alzheimer's drug, stock soars
Embed this video
Share
Description
Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer's treatment after abandoning the drug earlier this year. Freddie Joyner has the story.
General Info
UploadedOct 22, 2019
watch more videos